Leman Biotech

Developer and researcher of novel tumor immunotherapy drugs intended to serve the biotechnology. The company focuses on new tumor immunotherapy drugs based on immunometabolic reprogramming & artificial intelligence (AI), its team has developed the world's first Meta 10 immune metabolism reprogramming technology and established a technology platform for the discovery, development, and production of biological macromolecular drugs and new immune cell drugs.